METABOLOMICS Presented by IROA Technologies
PRESENTATION FLOW 1. What is metabolomics. 2. Emerging field of metabolomics. 3. Benefits of its application. 4. Contact us.
ABOUT METABOLOMICS Metabolomics is the scientific study of chemical processes involving metabolites, the small molecule substrates, intermediates and products of cell metabolism. What are metabolomics used for? Metabolomics is an objective lens to view the complex nature of how physiology is linked to external events and conditions, as well as measure its response to perturbations such as those associated with disease. What are the advantages of metabolomics? Studying the metabolome is advantageous for several reasons including, The metabolome provides the closest link to the phenotype of an organism. The analytical approaches are transferable across different biological systems. Metabolism is highly conserved across biology.
A LITTLE ABOUT THE EMERGING FIELD OF METABOLOMICS In this computerized era, almost everything utilizes technological advances to devise new mechanisms and make discoveries. The same is the case with biological data and Medical Sciences and this combination will certainly lead to dynamic discoveries and developments. With new demands to make advancements that meet the needs of an aging population and one with a limited food supply, the medical sciences, and IT sectors are emerging. One of the very exciting technologies that have resulted in metabolomics.
BENEFITS OF ITS APPLICATION Metabolomics allows healthcare professionals and scientists to get a proper readout of the metabolism in the body, all the way from the food components in a person to the drugs and other toxins from the environment that might have entered the cell. Hence, there are uncountable advantages that need to be put under light. Let’s get started! Scientists can use metabolomics to develop biomarkers that can also be used in clinical settings. Before its emergence, it was very difficult to identify biochemical biomarkers. Metabolomics has enabled the discovery of many new potential biomarkers but they will still require clinical validation before the derived information can be used beneficially.
CONTACT US www.iroatech.com
734.265.0884
info@iroatech.com